重组人生长激素治疗特发性矮小症的现状
HEALTHMUST-READMAGAZINE(2013)
Abstract
身材矮小是儿科医师最常遇到的主诉,上海地区的平均矮小症的患病率为3.77%[1].而特发性矮小(ISS)在所有矮小症中占60-80%[2],而由于其发病机制不明,个体间治疗疗效差异巨大,临床对于ISS的研究一直是个热点与难点.
MoreAI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined